Trillium Therapeutic (TRIL)

18.44  +0.47 (+2.62%)

After market: 18.47 +0.03 (+0.16%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2021-9-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
40.00K150.00K120.00K0.000.00
Operating Expenses
57.52M61.60M32.41M37.43M31.58M
Research and Development
35.55M25.35M26.69M29.49M25.98M
Selling, General, and Administrative Expenses
21.96M36.26M5.72M3.85M2.97M
Operating Income
-57.47M-61.46M-32.29M-37.43M-31.58M
Interest Income/Expense
1.81M2.21M-5.77M4.57M-3.16M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/A0.00N/A
Income Before Taxes
-55.66M-59.24M-38.05M-32.86M-34.74M
Income Tax
237.00K100.00K30.00K10.00K0.00
Net Income
-55.90M-59.35M-38.08M-32.87M-34.75M
EBITDA
-57.17M-60.87M-31.68M-34.99M-27.96M
 
Per Share Data
EPS Diluted Total Ops
-0.54-0.70-1.51-2.36-3.56
Non GAAP EPS
N/A-0.79-1.68-2.36-3.59
 
Statistics
Profit Margin
-139737.50%-39566.67%-31733.33%N/AN/A
Operating Profit Margin
-143667.50%-40973.33%-26908.33%N/AN/A

All data in USD

Charts